title: Reversal of slow flow phenomenon during primary stenting by bail-out administration of abciximab.
abstract: BACKGROUND: Slow flow or no reflow phenomenon is increasingly being recognized as a serious problem during coronary angioplasty and stenting. This phenomenon is seen more often during angioplasty in highly thrombogenic milieux, especially in a setting of acute myocardial infarction. The treatment of this complication is often not satisfactory. In this study the authors assessed the efficacy of abciximab, a potent antiplatelet drug, in treating slow flow or no reflow phenomenon during primary percutaneous transluminal coronary angioplasty (PTCA) for acute myocardial infarction (AMI). METHODS: Twenty-one instances of persistent slow flow phenomenon were encountered in 131 consecutive patients subjected to primary PTCA for AMI (16%). It was more common in patients presenting with AMI complicated by cardiogenic shock (nine of 21, 43%). Of these 21 cases of slow flow, 10 patients were given injection abciximab during the procedure of primary PTCA as a bail-out measure after encountering the complication of slow flow or no reflow. A pre-discharge coronary angiography was carried out in all patients who survived. RESULTS: In seven of 10 patients in the abciximab group flow had improved to TIMI-3. In contrast, in the non-abciximab group TIMI flow improved in only four of 11 patients. Patients with persistent slow flow had significantly higher mortality at the first 30-day follow-up than patients with TIMI-3 flow (33% versus 1.8%, p<0.001). CONCLUSION: In this small nonrandomized study significant improvement in coronary flow was achieved by using intravenous abciximab after observing slow flow or no reflow phenomenon during primary PTCA. More frequent use of this drug in this milieu might help in preventing the development of this complication. Larger studies are warranted to confirm this life-saving beneficial effect of bail-out administration of abciximab during primary angioplasty.
authors.affiliation: Department of Interventional Cardiology, Batra Hospital & Medical Research Centre, New Delhi, India.
authors.forename: Upendra
authors.initials: U
authors.lastname: Kaul
authors.forename: Rakesh
authors.initials: R
authors.lastname: Sapra
authors.forename: Balbir
authors.initials: B
authors.lastname: Singh
authors.forename: Dinesh
authors.initials: D
authors.lastname: Sudan
authors.forename: Tapan
authors.initials: T
authors.lastname: Ghose
authors.forename: N S
authors.initials: NS
authors.lastname: Dixit
authors.forename: H S
authors.initials: HS
authors.lastname: Wasir